By Josh White
Date: Friday 23 May 2025
(Sharecast News) - Poolbeg Pharma announced on Friday that it has conditionally raised a total of £4.865m in gross proceeds through an upsized and oversubscribed BookBuild offer, placing, and subscription.
GSK's COPD treatment approved by FDA | 23-May-2025 | ShareCast |
Faron Pharmaceuticals appoints chief business of... | 21-May-2025 | ShareCast |
Broker tips: Kingfisher, Accesso, Hikma | 20-May-2025 | ShareCast |
RBC Capital ups price target on Hikma | 20-May-2025 | ShareCast |
Poolbeg raises nearly £5m to progress clinical t... | 20-May-2025 | ShareCast |
Holding(s) in Company | 23-May-2025 | 17:53 | RNS |
Publication of a Prospectus | 23-May-2025 | 13:08 | RNS |
TR-1: Notification of major holdings | 23-May-2025 | 12:37 | RNS |
positive CHMP opinion on Blenrep in EU | 23-May-2025 | 12:16 | RNS |
Director/PDMR Shareholding | 23-May-2025 | 10:00 | RNS |
Questor :GW Pharmaceuticals | 04-Dec-2014 | Telegraph |
Questor : Hikma Pharmaceuticals | 13-Mar-2014 | Telegraph |
Investment Column:BTG | 06-Oct-2011 | The Independent |
Investment Column:Genus | 09-Sep-2011 | The Independent |
Questor :Dechra Pharmaceuticals | 08-Sep-2011 | Telegraph |
Price | 20,600.03 |
Closing Price Change | 67.97 |
% Change | 0.33 % |
23-May-25 Close | 20,600.03 |
You are here: research